These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 4975896

  • 1. [Prevention of RH-erythroblastosis by anti-D-application to the mother].
    Stahl M, Althoff W, Schellong G.
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):236-8. PubMed ID: 4975896
    [No Abstract] [Full Text] [Related]

  • 2. [Prevention of hemolytic disease of the newborn with anti-D administration to the mother. 2].
    Dtsch Med Wochenschr; 1968 Jun 14; 93(24):1176-9. PubMed ID: 4967928
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of haemolytic disease of the newborn by anti-D serum given to the mother.
    Schneider J, Preisler O, Haering M, Krüger H, Welsch H, Althoff W, Stahl M, Schellong G.
    Ger Med Mon; 1967 Dec 14; 12(12):570-1. PubMed ID: 4967929
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of Rho hemolytic disease of the newborn: the rosette method--a rapid, sensitive screening test.
    Taswell HF, Reisner RK.
    Mayo Clin Proc; 1983 May 14; 58(5):342-3. PubMed ID: 6405102
    [No Abstract] [Full Text] [Related]

  • 5. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J, Gryglicka M.
    Acta Haematol Pol; 1988 May 14; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of Rh sensitization from fetomaternal microtransfusions.
    Schneider J, Preisler O.
    Obstet Gynecol; 1966 Nov 14; 28(5):615-21. PubMed ID: 4958982
    [No Abstract] [Full Text] [Related]

  • 7. [Different aspects of using antirhesus immunoglobulin].
    Belozerova VI.
    Probl Gematol Pereliv Krovi; 1979 Oct 14; 24(10):49-54. PubMed ID: 92019
    [No Abstract] [Full Text] [Related]

  • 8. [Fetomaternal transfusion, Rhesus immunization and prevention. II. Rhesus immunization and prevention].
    Helderweirt G.
    Verh K Acad Geneeskd Belg; 1976 Oct 14; 38(3-4):79-134. PubMed ID: 826036
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Actual possibilities of prevention of serologic incompatibility].
    Breborowicz H, Gerwelowa H, Krawczyńska Z, Baraniecka K, Gruszczyńska J, Karowa L.
    Pol Tyg Lek; 1968 Sep 26; 23(35):1305-7. PubMed ID: 4972438
    [No Abstract] [Full Text] [Related]

  • 14. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K, Poschmann A.
    Immun Infekt; 1976 Dec 26; 4(6):249-60. PubMed ID: 828142
    [Abstract] [Full Text] [Related]

  • 15. Rh immunization.
    Wake EJ.
    Transfusion; 1977 Dec 26; 17(3):291-2. PubMed ID: 405759
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Preliminary experiences with the prevention of Rh sensitization].
    Aeppli H, Nwebube G.
    Gynaecologia; 1969 Dec 26; 168(6):481-3. PubMed ID: 4993890
    [No Abstract] [Full Text] [Related]

  • 18. [Anti-D treatment after mismatched transfusion: prevention of Rh sensitization].
    Schellong G, Grimm W.
    Dtsch Med Wochenschr; 1970 Dec 18; 95(51):2555-9. PubMed ID: 4998366
    [No Abstract] [Full Text] [Related]

  • 19. [Preliminary experiences with ther prevention of Rh sensitization].
    Aeppli H, Nwebube G.
    Gynaecologia; 1969 Dec 18; 168(6):481-3. PubMed ID: 4993202
    [No Abstract] [Full Text] [Related]

  • 20. Prophylaxis of maternal RH-sensitization by means of anti-D immunoglobulin.
    Petrov-Maslakov MA, Vasilyeva ZF, Matveyeva OF, Balasanyan IG, Sorina LI, Prigarnova TK.
    Arch Immunol Ther Exp (Warsz); 1971 Dec 18; 19(3):343-8. PubMed ID: 4999474
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.